Publication of Suppl.ProspctsSource: RNS
Publication of Supplementary Prospectus by Westpac Banking Corporation
The following Supplementary Prospectus has been approved by the United Kingdom Listing Authority (the "UKLA") and is available for viewing:
Supplementary Prospectus dated 7 May 2019 (the "Supplementary Prospectus") to the Base Prospectus dated 8 November 2018 (the "Base Prospectus"), relating to the U.S.$70 billion Programme for the Issuance of Debt Instruments established by Westpac Banking Corporation ("Westpac").
To view the Supplementary Prospectus in full, please paste the following URL into the address bar of your browser:
Copies of the Supplementary Prospectus have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM. For further information, please contact:
Westpac Banking Corporation
23 Camomile Street
London EC3A 7LL
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Supplementary Prospectus and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.
This publication does not constitute an offer of the debt instruments (the "Debt Instruments") for sale in the United States, and is not for distribution in or into the United States. The Debt Instruments have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or any relevant securities laws of any state of the United States, and may not be offered, sold or delivered in the United States or to, or for the account or benefit of, U.S. persons, as such terms are defined in Regulation S under the Securities Act, unless in a transaction exempt from registration under the Securities Act and any other securities law. The Debt Instruments will only be offered and sold without registration under the Securities Act to (a) "qualified institutional buyers" as defined in Rule 144A under the Securities Act ("Rule 144A") in reliance upon the exemptions provided by Section 4(2) of, and Rule 144A under, the Securities Act; and (b) non-U.S. persons in offshore transactions in reliance upon Regulation S under the Securities Act.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org or visit www.rns.com.